Form 4 for RMD ResMed|
Accepted 2023-04-05 00:00:00 ET · period of report 2023-04-03 · accession 0001127602-23-012530 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-05 | 2023-04-03 | RMD | PENDARVIS DAVID | Chief Administrative Off | S - Sale | $218.23 | -1,500 | 92.7K | -2% | -$327.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2023-04-03 | S | D | 1,500 | $218.23 | 92,672 | D | — | — |